InvestorsHub Logo
Followers 19
Posts 1991
Boards Moderated 0
Alias Born 02/25/2017

Re: None

Tuesday, 03/28/2017 7:57:40 AM

Tuesday, March 28, 2017 7:57:40 AM

Post# of 106837
A lot of our clinical data for these trials are coming from overseas. Mexico, Europe, Asia... its all in the stickies and links above. Imo a lot of the big money coming in now is also from overseas as the pivotal trials are FINALLY coming to an end. Now think about it. What happens when the FDA gives a thumbs up for RMAT designation? BIG US money comes in. This is an international powerhouse just getting started. Hold on tight